Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$143,569,383
+$30,606,912 QoQ
Shares Held
119,698
-2.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#318
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. LLY ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,569,383 | 119,698 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $112,962,471 | 122,816 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $150,918,399 | 140,431 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $133,046,599 | 174,373 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $136,692,922 | 175,353 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $141,275,207 | 171,054 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $142,579,136 | 184,688 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $216,784,200 | 244,694 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $251,455,712 | 277,735 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $242,448,899 | 311,647 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $332,579,757 | 570,541 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $175,633,989 | 326,986 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $179,488,023 | 382,720 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $138,012,597 | 401,877 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $148,257,755 | 405,253 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $103,828,977 | 321,104 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $146,490,031 | 451,809 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $131,785,181 | 460,192 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $130,528,312 | 472,552 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $67,749,173 | 293,223 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $66,255,079 | 288,668 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $53,047,164 | 283,948 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $26,390,704 | 156,306 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,830,613 | 113,705 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $20,064,437 | 122,210 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,017,386 | 72,213 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||